Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease

Background: The neural mechanisms and the circuitry involved in levodopa-induced dyskinesia (LID) are still partially obscure. LID can be considered the consequence of an abnormal pattern or code of activity that originates and is conveyed from the basal ganglia to the thalamus and the cortical motor areas. However, not only striatothalamocortical motor circuits but also other interconnected pathways could be implicated in its pathogenesis. Methods: In a series of experiments, we applied repetitive transcranial magnetic stimulation (rTMS) over the lateral cerebellum in a group of patients with advanced Parkinson disease, to investigate whether modulation of cerebellothalamocortical circuits by means of rTMS may result in a modification of a dyskinetic state induced by levodopa ingestion. Results: We found that a single session of cerebellar continuous theta burst stimulation (cTBS) was capable of transiently reducing LID. In the same patients, we observed that cerebellar cTBS changed the profile of activation of intracortical circuits in the contralateral primary motor cortex. Cerebellar cTBS reduced short intracortical inhibition and increased long intracortical inhibition, inducing a cortical reorganization that is associated with a reduction of LID. Furthermore, in another experiment, we observed that a 2-week course of bilateral cerebellar cTBS induced persistent clinical beneficial effects, reducing peak-dose LID for up to 4 weeks after the end of the daily stimulation period. Conclusions: Our study demonstrates that cerebellar continuous theta burst stimulation has an antidyskinetic effect in Parkinson disease patients with levodopa-induced dyskinesia, possibly due to modulation of cerebellothalamocortical pathways.

[1]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[2]  J R Moeller,et al.  Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism. , 2001, Brain : a journal of neurology.

[3]  Deborah C Mash,et al.  Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT‐PCR , 2003, The European journal of neuroscience.

[4]  R. Mailman,et al.  Task specific influences of Parkinson’s disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries , 2007, Neuroscience.

[5]  C. Marsden,et al.  Corticocortical inhibition in human motor cortex. , 1993, The Journal of physiology.

[6]  Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trial of remacemide in advanced Parkinson disease. , 2001, Archives of neurology.

[7]  M. Hallett,et al.  Human motor evoked responses to paired transcranial magnetic stimuli. , 1992, Electroencephalography and clinical neurophysiology.

[8]  J. Dostrovsky,et al.  Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine. , 2000, Annals of neurology.

[9]  R. Hanajima,et al.  Magnetic stimulation over the cerebellum in humans , 1995, Annals of neurology.

[10]  D. Brooks,et al.  A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. , 2000, The New England journal of medicine.

[11]  Sara Torriero,et al.  Increased facilitation of the primary motor cortex following 1Hz repetitive transcranial magnetic stimulation of the contralateral cerebellum in normal humans , 2005, Neuroscience Letters.

[12]  P. Remy,et al.  Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT‐PD) , 1999, Movement disorders : official journal of the Movement Disorder Society.

[13]  Emanuele Lo Gerfo,et al.  Changes in intracortical circuits of the human motor cortex following theta burst stimulation of the lateral cerebellum , 2008, Clinical Neurophysiology.

[14]  Ulf Ziemann,et al.  The role of GABA(B) receptors in intracortical inhibition in the human motor cortex. , 2006, Experimental brain research.

[15]  S Fahn,et al.  The spectrum of levodopa-induced dyskinesias. , 2000, Annals of neurology.

[16]  C. Tsai,et al.  Pallidotomy effect on the cortical excitability in patients with severe Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[17]  C Caltagirone,et al.  rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease , 2005, Neurology.

[18]  M. S. Young,et al.  Stereotactic pallidotomy lengthens the transcranial magnetic cortical stimulation silent period in Parkinson's disease , 1997, Neurology.

[19]  Patrick Ragert,et al.  Contribution of transcranial magnetic stimulation to the understanding of cortical mechanisms involved in motor control , 2008, The Journal of physiology.

[20]  Ji Hyun Ko,et al.  Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: The contribution of expectation , 2006, NeuroImage.

[21]  R A Bakay,et al.  Ablative surgery and deep brain stimulation for Parkinson's disease. , 1999, Neurosurgery.

[22]  P. Strick,et al.  The cerebellum communicates with the basal ganglia , 2005, Nature Neuroscience.

[23]  T. Tominaga,et al.  The role of sigma-receptors in levodopa-induced dyskinesia in patients with advanced Parkinson disease: a positron emission tomography study. , 2004, Journal of neurosurgery.

[24]  M. Desmurget,et al.  Motor urgency is mediated by the contralateral cerebellum in Parkinson’s disease , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[25]  Paul Greengard,et al.  Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia , 2003, Nature Neuroscience.

[26]  J. Rothwell,et al.  Theta Burst Stimulation of the Human Motor Cortex , 2005, Neuron.

[27]  J. Obeso,et al.  L-dopa-induced dyskinesia and stereotactic surgery for Parkinson's disease. , 2008, Neurosurgery.

[28]  Masao Ito Control of mental activities by internal models in the cerebellum , 2008, Nature Reviews Neuroscience.

[29]  Viviana Versace,et al.  Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson’s disease , 2006, Clinical Neurophysiology.

[30]  D. Centonze,et al.  Mechanisms of Disease: basic-research-driven investigations in humans—the case of hyperkinetic disorders , 2007, Nature Clinical Practice Neurology.

[31]  A. E. Lang,et al.  Breast cancer at site of implanted vagus nerve stimulator , 2007, Neurology.

[32]  O Rascol A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group , 2000 .

[33]  Alexander Münchau,et al.  Repeated premotor rTMS leads to cumulative plastic changes of motor cortex excitability in humans , 2003, NeuroImage.

[34]  John C Rothwell,et al.  Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[35]  T. Tominaga,et al.  The role of σ-receptors in levodopa-induced dyskinesia in patients with advanced Parkinson disease: a positron emission tomography study , 2004 .

[36]  J. Rothwell,et al.  Techniques and mechanisms of action of transcranial stimulation of the human motor cortex , 1997, Journal of Neuroscience Methods.

[37]  J Valls-Solé,et al.  Akinesia in Parkinson's disease. II. Effects of subthreshold repetitive transcranial motor cortex stimulation , 1994, Neurology.

[38]  Erwan Bezard,et al.  Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies , 2001, Nature Reviews Neuroscience.

[39]  P. Ashby,et al.  Pallidotomy Increases Cortical Inhibition in Parkinson's Disease , 1997, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[40]  Hong Yu,et al.  Role of hyperactive cerebellum and motor cortex in Parkinson's disease , 2007, NeuroImage.

[41]  J. Rothwell,et al.  Clinical applications of transcranial magnetic stimulation in patients with movement disorders , 2008, The Lancet Neurology.

[42]  D J Brooks,et al.  Neuroimaging of dyskinesia. , 2000, Annals of neurology.